Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Dec 7;14(6):804-10.
doi: 10.1016/j.cmet.2011.11.004.

Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease

Affiliations
Case Reports

Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease

Nishanth E Sunny et al. Cell Metab. .

Abstract

Approximately one-third of the U.S. population has nonalcoholic fatty liver disease (NAFLD), a condition closely associated with insulin resistance and increased risk of liver injury. Dysregulated mitochondrial metabolism is central in these disorders, but the manner and degree of dysregulation are disputed. This study tested whether humans with NAFLD have abnormal in vivo hepatic mitochondrial metabolism. Subjects with low (3.0%) and high (17%) intrahepatic triglyceride (IHTG) were studied using (2)H and (13)C tracers to evaluate systemic lipolysis, hepatic glucose production, and mitochondrial pathways (TCA cycle, anaplerosis, and ketogenesis). Individuals with NAFLD had 50% higher rates of lipolysis and 30% higher rates of gluconeogenesis. There was a positive correlation between IHTG content and both mitochondrial oxidative and anaplerotic fluxes. These data indicate that mitochondrial oxidative metabolism is ~2-fold greater in those with NAFLD, providing a potential link between IHTG content, oxidative stress, and liver damage.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Glucose and Mitochondrial Fat Metabolism in Human Subjects with Low or High IHTG Content
2H and 13C isotopomer analysis of plasma glucose and β-hydroxybutyrate by NMR and FFA by GC-MS was used to determine hepatic flux in overnight fasted individuals. Shown are (A) endogenous glucose production and its contributions from gluconeogenesisand glycogenolysis in hexose units, (B) anaplerotic flux as an estimateofpyruvate carboxylase and PEPCK flux and its contribution to pyruvate cycling and gluconeogenesis, (C) hepatic TCA cyclefluxinacetyl-CoA units, (D) apparent β-hydroxybutyrate turnover as an estimate of ketogenesis; (E) correlation between TCA cycle flux and anaplerosis; and (F) FFA turnover as an estimate of systemic lipolysis. Data are presented as means ±SEM (n = 8) with significance declared at p ≤ 0.05 and p ≤ 0.1 considered a trend.
Figure 2
Figure 2. Hepatic Mitochondrial Metabolism Is Increased in Subjects with Nonalcoholic Fatty Liver Disease
Subjects with increased IHTG had elevated adipose lipolysis which contributed to increased lipid delivery to liver. Hepatic TCA cycle flux was increased, indicating upregulated mitochondrial respiration (at least via complex II) and suggesting increased flux of acetyl-CoA from β-oxidation. Mitochondrial anaplerosis was also increased and provided substrate for the increased rate of gluconeogenesis observed in subjects with high IHTG. Pathways that are increased during high IHTG are designated by ↑.

Comment in

References

    1. Barrows BR, Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab. 2006;91:1446–1452. - PubMed
    1. Bickerton A, Roberts R, Fielding B, Tornqvist H, Blaak E, Wagenmakers A, Gilbert M, Humphreys S, Karpe F, Frayn K. Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia. 2008;51:1466–1474. - PubMed
    1. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther. 2003;5:1003–1015. - PubMed
    1. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114:147–152. - PMC - PubMed
    1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395. - PubMed

Publication types